MA51840A - Modulateurs de somatostatine et leurs utilisations - Google Patents

Modulateurs de somatostatine et leurs utilisations

Info

Publication number
MA51840A
MA51840A MA051840A MA51840A MA51840A MA 51840 A MA51840 A MA 51840A MA 051840 A MA051840 A MA 051840A MA 51840 A MA51840 A MA 51840A MA 51840 A MA51840 A MA 51840A
Authority
MA
Morocco
Prior art keywords
somatostatin modulators
somatostatin
modulators
Prior art date
Application number
MA051840A
Other languages
English (en)
French (fr)
Inventor
Shimiao Wang
Jian Zhao
Yunfei Zhu
Original Assignee
Crinetics Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinetics Pharmaceuticals Inc filed Critical Crinetics Pharmaceuticals Inc
Publication of MA51840A publication Critical patent/MA51840A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA051840A 2018-02-12 2019-02-11 Modulateurs de somatostatine et leurs utilisations MA51840A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862629377P 2018-02-12 2018-02-12
US201862673042P 2018-05-17 2018-05-17
US201862724421P 2018-08-29 2018-08-29

Publications (1)

Publication Number Publication Date
MA51840A true MA51840A (fr) 2021-05-19

Family

ID=67548490

Family Applications (1)

Application Number Title Priority Date Filing Date
MA051840A MA51840A (fr) 2018-02-12 2019-02-11 Modulateurs de somatostatine et leurs utilisations

Country Status (5)

Country Link
US (1) US11608335B2 (https=)
EP (1) EP3752498B1 (https=)
JP (1) JP7365347B2 (https=)
MA (1) MA51840A (https=)
WO (1) WO2019157458A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018170284A1 (en) 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3752498B1 (en) 2018-02-12 2023-06-28 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
AR116424A1 (es) 2018-09-18 2021-05-05 Crinetics Pharmaceuticals Inc Moduladores de la somatostatina y usos de los mismos
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途
EP4294797A1 (en) 2021-02-17 2023-12-27 Crinetics Pharmaceuticals, Inc. Crystalline forms of a somatostatin modulator
CA3207382A1 (en) * 2021-02-17 2022-08-25 Christine FERRARA-COOK Somatostatin receptor type 5 agonist for the treatment of hyperinsulinism
AU2023366475A1 (en) * 2022-10-28 2025-05-29 Exelixis, Inc. Somatostatin receptor 2 agonists and uses thereof
JP2026500913A (ja) 2022-12-13 2026-01-09 クリネティックス ファーマシューティカルズ,インク. ソマトスタチンサブタイプ-2受容体(sst2r)標的化治療薬及びその使用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127343A (en) 1996-05-14 2000-10-03 Novo Nordisk A/S Somatostatin agonists and antagonists
US6025372A (en) 1997-04-04 2000-02-15 Merck & Co., Inc. Somatostatin agonists
FR2802206B1 (fr) 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
US20060281764A1 (en) 2005-06-10 2006-12-14 Gaul Michael D Aminopyrimidines as kinase modulators
CA2644929A1 (en) * 2006-03-13 2008-05-02 Merck & Co., Inc. Somatostatin agonists
EP2054385A2 (en) 2006-08-15 2009-05-06 F. Hoffmann-Roche AG Phenyl, pyridine and quinoline derivatives
EP2211619A1 (en) 2007-10-18 2010-08-04 Merck Sharp & Dohme Corp. Substituted 1,2,4-oxadiazoles and analogs thereof as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases
CA2729220A1 (en) 2008-06-25 2009-12-30 Envivo Pharmaceuticals, Inc. Di-substituted phenyl compounds
GB0818241D0 (en) 2008-10-06 2008-11-12 Cancer Res Technology Compounds and their use
CA2772194A1 (en) 2009-09-01 2011-03-10 Pfizer Inc. Benzimidazole derivatives
CA2799414A1 (en) 2010-05-18 2011-11-24 Merck Sharp & Dohme Corp. Spiro isoxazoline compounds as sstr5 antagonists
GB201008290D0 (en) 2010-05-18 2010-06-30 Syngenta Ltd Chemical compounds
WO2014007228A1 (ja) * 2012-07-03 2014-01-09 小野薬品工業株式会社 ソマトスタチン受容体作動活性を有する化合物およびその医薬用途
AU2014325078B2 (en) * 2013-09-30 2018-10-25 Ono Pharmaceutical Co., Ltd. Compound having agonistic activity to somatostatin receptor and medicinal use thereof
CN105579524B (zh) 2013-10-02 2018-05-04 株式会社可乐丽 树脂组合物、多层片、包装材料和容器
HRP20221279T1 (hr) 2016-07-14 2022-12-23 Crinetics Pharmaceuticals, Inc. Modulatori somatostatina i njihove uporabe
CN110300749A (zh) 2017-02-08 2019-10-01 小野药品工业株式会社 具有生长抑素受体激动活性的化合物及其医药用途
WO2018170284A1 (en) * 2017-03-16 2018-09-20 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
US11028068B2 (en) 2017-07-25 2021-06-08 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
EP3752498B1 (en) 2018-02-12 2023-06-28 Crinetics Pharmaceuticals, Inc. Somatostatin modulators and uses thereof
AR116424A1 (es) 2018-09-18 2021-05-05 Crinetics Pharmaceuticals Inc Moduladores de la somatostatina y usos de los mismos
TWI841768B (zh) 2019-08-14 2024-05-11 美商克林提克斯醫藥股份有限公司 非肽生長抑制素(somatostatin)5型受體激動劑及其用途

Also Published As

Publication number Publication date
EP3752498B1 (en) 2023-06-28
US20210040087A1 (en) 2021-02-11
JP2021512889A (ja) 2021-05-20
US11608335B2 (en) 2023-03-21
EP3752498A4 (en) 2021-11-03
JP7365347B2 (ja) 2023-10-19
EP3752498A1 (en) 2020-12-23
WO2019157458A1 (en) 2019-08-15

Similar Documents

Publication Publication Date Title
EP3484865A4 (en) SOMATOSTATIN MODULATORS AND USES THEREOF
EP3853218A4 (en) SOMATOSTATIN MODULATORS AND USES THEREOF
MA51840A (fr) Modulateurs de somatostatine et leurs utilisations
EP3817822A4 (en) PROTEIN DEGRADANTS AND USES THEREOF
MA50256A (fr) Composés de pyrazolopyrimidinone et leurs utilisations
MA50618A (fr) Polyrhérapies et leurs utilisations
EP3787607C0 (en) CAROTINOID COMPOSITIONS AND USES THEREOF
EP3523294A4 (en) CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF
EP3810182A4 (en) Neoantigens and uses thereof
EP3749318A4 (en) GAMMA-POLYGLUTAMATED RALTITREXED AND ITS USES
EP3749315A4 (en) ALPHA-POLYGLUTAMATED RALTITREXED AND USES THEREOF
EP3490565A4 (en) CHEMOKIN RECEPTOR MODULATORS AND USES THEREOF
EP3902530A4 (en) Polymeric nanovaccines and uses thereof
MA52365A (fr) Composés et leurs utilisations
EP3917527A4 (en) CONNECTIONS AND USES THEREOF
MA52092A (fr) Composés et leurs utilisations
EP4093768A4 (en) CAL-T CONSTRUCTS AND USES THEREOF
EP3638251A4 (en) BISPHOSPHOCINGLE GEL FORMULATIONS AND USES THEREOF
EP3893945A4 (en) CROMOLYNESTERS AND USES THEREOF
EP3364958A4 (en) MODULATORS OF SESTRINE-GATOR2 INTERACTION AND USES THEREOF
EP3914245A4 (en) MTORC-1 MODULATORS AND USES THEREOF
EP3841096A4 (en) PYRIDINYLMETHYLENEPIPERIDEINDIVATES AND THEIR USES
EP3790883A4 (en) Heteroaryl compounds and uses thereof
EP3664799A4 (en) LINCOSAMIDE ANTIBIOTICS AND THEIR USES
EP3774737A4 (en) CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF